This activity is jointly provided by the Postgraduate Institute for Medicine, the Crohn's & Colitis Foundation, and RMEI Medical Education, LLC.
Supported by independent educational grants from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc.
In this educational activity, you will follow a patient whose symptoms are consistent with inflammatory bowel disease (IBD) and will have the opportunity to learn about diagnosis and treatment in an interactive format.
This program was intended for physicians, gastroenterologists, nurse practitioners, and physician assistants involved in the care of patients with inflammatory bowel disease (IBD).
After completing this activity, the participant will demonstrate the ability to:
Describe indications for and interpretation of diagnostic testing in inflammatory bowel disease
Apply principles of therapeutic management according to clinical symptoms, duration, and severity of disease
Conflict Of Interest Disclosure Policy
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Hans Herfarth, MD, PhD Professor of Medicine University of North Carolina Chapel Hill, NC
Dr. Herfarth has affiliations with Alivio, AMAG, Allergan, Boehringer-Ingelheim, Celtrion, Finch, Lycera, Merck, Pfizer, PureTech, Seres, (Consultant); Artizan, Pfizer (Research)
Miguel Regueiro, MD Chair, Department of Gastroenterology and Hepatology Professor, Lerner College of Medicine Cleveland Clinic Cleveland, OH
The PIM planners and managers have nothing to disclose.
RMEI Medical Education, LLC planners and managers have nothing to disclose.
AMA PRA Category 1 Credit(s)TM
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.
There is no fee for this educational activity.
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive up to 1.00 AMA PRA Category 1 Credit(s)TM. A statement of credit will be available to print from your user history page. Users must:
Read the learning objectives and faculty disclosures.
Participate in the activity.
Complete the activity post-test and evaluation.
Physicians who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation. A copy of your certificate will be saved in your CME History on myCME.